Hormones are the primary source of prostate cancer growth. Also, it can help the cancer to progress and grow in the body. Moreover, the cancer cells rely on male hormones for their replication. On the other hand, doctors use treatments to reduce androgen levels and block signaling pathways. This can decrease cancer spread and load in the body.
What Are Hormones?
The hormones are responsible for acting as the chemical messengers in the body. Moreover, it is produced by specific glands which then travel through the bloodstream to different organs and tissues. In addition, this can help in growth, metabolism, reproduction, mood, and sleep.
What Are Androgens?
Androgens are a group of sex hormones which enhance male reproductive health. Also, it is produced from testes, ovaries, and adrenal glands. This is found in both males and females but in a higher amount in males. Furthermore, they are steroid hormones derived from cholesterol.
How Do Hormones Affect the Prostate?
These hormones can aid in the growth, and function of the prostate gland. Moreover, testosterone is reduced with stable estrogen and build up of DHT. It can cause increased cell proliferation, leading to prostate cancer.
What Is Androgen Receptor Signaling?
Androgen receptor signaling is termed a biological pathway to regulate gene expression. Also, male sex hormones bind to androgen receptors present in the prostate gland. In addition, it can help in male sexual enhancement and muscle and bone growth.
Hormone Therapy in Prostate Cancer
Hormone therapy for cancer in the prostate works by decreasing testosterone levels. Furthermore, it can block the hormone from promoting cancer growth. There are different therapies, like:
- Androgen Deprivation Therapy: It can stop testes from producing testosterone
- Antiandrogens: This can block androgens from reaching cancer cells.
- Androgen Synthesis Inhibitors: It can inhibit enzymes which stops producing androgens
Benefits of Understanding Hormone Biology
There are certain benefits, like:
- Optimized Metabolism
- Weight Management
- Mood enhance
- Increase Reproductive Health
- Better Sleep
The Future of Hormone-Based Treatment
The future of hormone-based therapies relies on precision medicine, proactive longevity, and delivery. Moreover, it can help doctors determine the correct dosage for treatments. Also, smart delivery can aid patients in getting complete absorption with frequent timings. Furthermore, therapies can block receptors, hormone production and signaling pathways.
Conclusion
Hormones are an essential part of bodily function. However, it can help cancer cells to grow and divide. Also, these can increase cancer progression in the body. The cancer depends on male sex hormones like testosterone for growth. Therefore, doctors use therapies to block the binding and working of hormones. On the other hand, patients avoid using chemotherapies, as they kill all rapid-dividing cells. This can also affect the healthy cells inside the body. Thus, precision medicines target the cancer cells specifically.
FAQs
What are the benefits of precision medicine in prostate cancer?
Precision medicine treats cancers without affecting the healthy cells. Moreover, it can help to avoid side effects and decrease cancer progression.
How does testosterone help prostate cancer grow?
The male sex hormones bind to androgen receptors in the prostate cells. Furthermore, the binding can create growth signals for cancer cells. Thus, helping them to grow and divide.
References
- Shaneyfelt, T., Husein, R., Bubley, G., & Mantzoros, C. S. (2000). Hormonal predictors of prostate cancer: a meta-analysis. Journal of Clinical Oncology, 18(4), 847-847. https://ascopubs.org/doi/abs/10.1200/jco.2000.18.4.847
- Taplin, M. E., & Ho, S. M. (2001). The endocrinology of prostate cancer. The Journal of Clinical Endocrinology & Metabolism, 86(8), 3467-3477. https://academic.oup.com/jcem/article-abstract/86/8/3467/2848333
- Mostaghel, E. A. (2013). Steroid hormone synthetic pathways in prostate cancer. Translational andrology and urology, 2(3), 212. https://pmc.ncbi.nlm.nih.gov/articles/PMC4219921/
- Hsing, A. W., Reichardt, J. K., & Stanczyk, F. Z. (2002). Hormones and prostate cancer: current perspectives and future directions. The Prostate, 52(3), 213-235. https://onlinelibrary.wiley.com/doi/abs/10.1002/pros.10108
- Sofikerim, M., Eskicorapcı, S., Oruç, Ö., & Özen, H. (2007). Hormonal predictors of prostate cancer. Urologia Internationalis, 79(1), 13-18. https://karger.com/uin/article-abstract/79/1/13/309751/Hormonal-Predictors-of-Prostate-Cancer
